Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

UNITED THERAPEUTICS (UTHR) Equity Income: 2009-2012

Historic Equity Income for UNITED THERAPEUTICS (UTHR) over the last 4 years, with Dec 2012 value amounting to -$143,000.

  • UNITED THERAPEUTICS's Equity Income fell 71.43% to -$72,000 in Q2 2013 from the same period last year, while for Jun 2013 it was -$200,000, marking a year-over-year decrease of 75.44%. This contributed to the annual value of -$143,000 for FY2012, which is 20.17% down from last year.
  • As of FY2012, UNITED THERAPEUTICS's Equity Income stood at -$143,000, which was down 20.17% from -$119,000 recorded in FY2011.
  • In the past 5 years, UNITED THERAPEUTICS's Equity Income registered a high of -$119,000 during FY2011, and its lowest value of -$160,000 during FY2010.
  • Moreover, its 3-year median value for Equity Income was -$143,000 (2012), whereas its average is -$140,667.
  • As far as peak fluctuations go, UNITED THERAPEUTICS's Equity Income rose by 25.62% in 2011, and later declined by 20.17% in 2012.
  • Over the past 4 years, UNITED THERAPEUTICS's Equity Income (Yearly) stood at -$141,000 in 2009, then fell by 13.48% to -$160,000 in 2010, then rose by 25.62% to -$119,000 in 2011, then dropped by 20.17% to -$143,000 in 2012.